Search all medical codes

Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; respiratory syncytial virus

CPT4 code

Name of the Procedure:

Infectious Agent Antigen Detection by Immunoassay Technique (e.g., Enzyme Immunoassay [EIA], Enzyme-Linked Immunosorbent Assay [ELISA], Immunochemiluminometric Assay [IMCA]) Qualitative or Semiquantitative, Multiple-Step Method; Respiratory Syncytial Virus (RSV)

Summary

This procedure involves detecting the presence of antigens from the Respiratory Syncytial Virus (RSV) using an immunoassay technique. It is a laboratory test that can either provide a qualitative (positive or negative) or semiquantitative (approximate amount) result. Commonly used techniques include Enzyme Immunoassay (EIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Immunochemiluminometric Assay (IMCA).

Purpose

The procedure is used to diagnose RSV infections, which are common in infants and young children and can lead to serious respiratory issues. The goal is to promptly and accurately identify the virus, enabling timely and appropriate treatment.

Indications

  • Symptoms such as coughing, wheezing, difficulty breathing, and fever.
  • Suspected RSV infection, particularly in vulnerable populations like infants, the elderly, or immune-compromised individuals.

Preparation

No specific preparation is typically required for the patient. However, it’s important to inform the healthcare provider of any medications currently being taken.

Procedure Description

  1. Sample Collection: A swab is taken from the patient's nose or throat.
  2. Antigen Detection: The collected sample is then processed using an immunoassay technique (EIA, ELISA, or IMCA), which involves multiple steps to detect the presence of RSV antigens.
  3. Analysis: The test yields a qualitative or semiquantitative result, indicating whether RSV antigens are present and, if semiquantitative, in what approximate amount.
  4. Equipment: Various laboratory tools and immunoassay kits specific to RSV detection.
  5. No Anesthesia or Sedation: This procedure is non-invasive and does not require anesthesia.

Duration

The test itself takes a few minutes to perform, but complete analysis and results may take several hours to a day, depending on the specific technique used and the laboratory's workflow.

Setting

This procedure is typically performed in a laboratory setting within a hospital or outpatient clinic.

Personnel

  • Lab technicians or medical technologists process and analyze the samples.
  • Medical professionals such as nurses or physicians may be involved in collecting the sample.

Risks and Complications

  • Mild discomfort or gagging during swab collection.
  • Rarely, there may be minor bleeding at the swab site.

Benefits

  • Early and accurate detection of RSV enables prompt treatment.
  • Can help prevent the spread of the virus, especially crucial in hospital environments or among vulnerable populations.

Recovery

  • No specific recovery process is needed as the procedure is minimally invasive.
  • Patients can resume normal activities immediately.

Alternatives

  • Other diagnostic methods such as Polymerase Chain Reaction (PCR), which may offer greater sensitivity.
  • Clinicians may also rely on clinical diagnosis based on symptoms and patient history, though this has limitations in accuracy.

Patient Experience

Patients might feel minor discomfort during the swab collection but generally do not experience significant pain. Any discomfort typically resolves quickly, and the procedure does not significantly impact daily activities.

Similar Codes